SCHEMBL20093439

SCHEMBL20093439

CC(C)Oc1ccc(-c2nn(CCC(C)Oc3ccc(F)c(-c4n[nH]c5ncnc(N)c45)c3)c3ncnc(N)c23)cc1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 14/20 0.46
▸ PIK3CG P48736 8/20 0.46
▸ PIK3CA P42336 7/20 0.46
▸ PIK3CB P42338 7/20 0.46
▸ PRKDC P78527 7/20 0.46
▸ SRC P12931 8/20 0.43
▸ ABL1 P00519 7/20 0.43
▸ HCK P08631 7/20 0.43
▸ FGFR4 P22455 1/20 0.43
▸ EGFR P00533 6/20 0.43
▸ KDR P35968 6/20 0.43
▸ MTOR P42345 6/20 0.43
▸ EPHB4 P54760 6/20 0.43
▸ PI4KB Q9UBF8 3/20 0.43
▸ CSNK1E P49674 3/20 0.42
▸ PIK3R1 P27986 1/20 0.41
▸ KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19414292 0.78 SRC (0.42) PIK3CGPIK3CBPRKDCSRCABL1
SCHEMBL13717800 0.78 CSNK1E (0.45) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL130467 0.74 PIK3CD (0.61) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL129575 0.70 SRC (0.53) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL13717774 0.69 PIK3CD (0.41) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL27943326 0.68 PIK3CD (0.50) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL26973954 0.68 KDR (0.50) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL217790 0.67 ABL1 (0.49) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL13717931 0.67 SRC (0.48) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC
SCHEMBL22854507 0.67 SRC (0.35) PIK3CDPIK3CGPIK3CAPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 — — US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 — — US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B PIK3CD 89/4885PIK3CG 128/4885PIK3CA 106/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB PIK3CD 47/4885PIK3CG 77/4885PIK3CA 88/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 PIK3CD 148/4885PIK3CG 194/4885PIK3CA 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback